PolyPeptide Group Price To Sales vs. Net Income
| PPGN Stock | CHF 28.95 0.45 1.58% |
For PolyPeptide Group profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PolyPeptide Group to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PolyPeptide Group AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PolyPeptide Group's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PolyPeptide Group AG over time as well as its relative position and ranking within its peers.
PolyPeptide |
PolyPeptide Group Net Income vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining PolyPeptide Group's current stock value. Our valuation model uses many indicators to compare PolyPeptide Group value to that of its competitors to determine the firm's financial worth. PolyPeptide Group AG is regarded third in price to sales category among its peers. It also is regarded third in net income category among its peers making up about 16,746,279 of Net Income per Price To Sales. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PolyPeptide Group's earnings, one of the primary drivers of an investment's value.PolyPeptide Net Income vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
PolyPeptide Group |
| = | 2.82 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
PolyPeptide Group |
| = | 47.26 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
PolyPeptide Net Income Comparison
PolyPeptide Group is currently under evaluation in net income category among its peers.
PolyPeptide Group Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in PolyPeptide Group, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PolyPeptide Group will eventually generate negative long term returns. The profitability progress is the general direction of PolyPeptide Group's change in net profit over the period of time. It can combine multiple indicators of PolyPeptide Group, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. The company was founded in 1952 and is headquartered in Zug, Switzerland. POLYPEPTIDE is traded on Switzerland Exchange in Switzerland.
PolyPeptide Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on PolyPeptide Group. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PolyPeptide Group position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PolyPeptide Group's important profitability drivers and their relationship over time.
Use PolyPeptide Group in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PolyPeptide Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PolyPeptide Group will appreciate offsetting losses from the drop in the long position's value.PolyPeptide Group Pair Trading
PolyPeptide Group AG Pair Trading Analysis
The ability to find closely correlated positions to PolyPeptide Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PolyPeptide Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PolyPeptide Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PolyPeptide Group AG to buy it.
The correlation of PolyPeptide Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PolyPeptide Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PolyPeptide Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PolyPeptide Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your PolyPeptide Group position
In addition to having PolyPeptide Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Funds Thematic Idea Now
Tech Funds
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for PolyPeptide Stock Analysis
When running PolyPeptide Group's price analysis, check to measure PolyPeptide Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPeptide Group is operating at the current time. Most of PolyPeptide Group's value examination focuses on studying past and present price action to predict the probability of PolyPeptide Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPeptide Group's price. Additionally, you may evaluate how the addition of PolyPeptide Group to your portfolios can decrease your overall portfolio volatility.